S&P 500
$5,916.93
+0.4%
+$24.35
DJI
$42,322.75
+0.6%
+$271.69
NASDAQ
$19,112.32
-0.2%
-$34.49
Bitcoin
$104,032.00
+1.2%
+$1,186.40
AAPL
$211.11
-0.6%
-$1.22
AMZN
$204.88
-2.6%
-$5.36
GOOG
$165.24
-0.9%
-$1.57
META
$643.49
-2.4%
-$15.87
MSFT
$452.47
-0.1%
-$0.47
NVDA
$134.64
-0.5%
-$0.70
TSLA
$342.64
-1.4%
-$5.04
Freeline Therapeutics Plc (NASDAQ: FRLN)
Some price data may be temporarily unavailable.
Freeline Therapeutics Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Freeline Therapeutics Plc Company Info
Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.